Your browser doesn't support javascript.
loading
Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.
Siemiatkowska, Anna; Bryl, Maciej; Kosicka-Noworzyn, Katarzyna; Tvrdon, Jakub; Golda-Gocka, Iwona; Glówka, Franciszek K.
Affiliation
  • Siemiatkowska A; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806, Poznan, Poland. asiemiatkowska@ump.edu.pl.
  • Bryl M; Department of Clinical Oncology with the Subdepartment of Diurnal Chemotherapy, Wielkopolska Center of Pulmonology and Thoracic Surgery, 62 Szamarzewskiego Street, 60-569, Poznan, Poland.
  • Kosicka-Noworzyn K; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806, Poznan, Poland.
  • Tvrdon J; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806, Poznan, Poland.
  • Golda-Gocka I; Department of Clinical Oncology with the Subdepartment of Diurnal Chemotherapy, Wielkopolska Center of Pulmonology and Thoracic Surgery, 62 Szamarzewskiego Street, 60-569, Poznan, Poland.
  • Glówka FK; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806, Poznan, Poland.
Cancer Immunol Immunother ; 72(6): 1853-1863, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36688998

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8 Antigens / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8 Antigens / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: